NCT05296564 2025-10-02Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic CancersHadassah Medical OrganizationPhase 1/2 Recruiting3 enrolled
NCT00007813 2020-02-17Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid TumorsSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Completed21 enrolled
NCT02457650 2016-08-03T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesShenzhen Second People's HospitalPhase 1 Unknown36 enrolled
NCT00293384 2016-03-15Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantBarbara Ann Karmanos Cancer InstitutePhase NA Completed40 enrolled 9 charts
NCT00003425 2013-04-26Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine CytoprotectUniversity of KentuckyPhase 1/2 Completed25 enrolled